Menu

Post image 1
Post image 2
1 / 2
0

H1 secures $40M from CVS, proving SaaS startups can still attract investment | TechCrunch

TechCrunch·Marina Temkin·4 days ago
#FHXP0MFP
Reading 0:00
15s threshold

It’s no secret that pre-AI era startups are generally getting little love from investors now. Ariel Katz, co-founder and CEO of a nine-year-old healthcare data platform H1 , argues that not all SaaS companies should be painted with the same broad brush. “If you’re a workflow SaaS company, you could vibe code that,” he told TechCrunch. What AI cannot easily replicate, according to Katz, is a company that is a data provider at its core. That’s a self-serving viewpoint — H1’s entire business is built on selling detailed information about doctors to pharma companies, hospital systems, and health insurers — but it doesn’t mean he is wrong. “I don’t worry about Claude ever doing what we do,” Katz said, referring to Anthropic’s popular AI model. He thinks that the data H1 collects on physicians globally could actually be so valuable to AI model makers that they are more likely to become customers than competitors.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.

Read More